Kineta: Kineta is a biotechnology company focused on developing novel drug candidates in three large high need therapeutic areas: autoimmune disease, viral disease and chronic pain. The Company has five unique drug programs in development and each program represents a novel mechanism-of-action and has potential to result in a new class of drug.

Drug Programs:
Phase I:
- Autoimmune program (MS, T1D, Lupus, etc.)
- Antiviral program (Flu, RSV, HCV, Dengue, WNV)

Pre-Clinical:
- Antiviral agonists (Flu, RSV)
- Vaccine adjuvants
- Chronic pain
Sector/industry:
Biotech Company
Characteristics:
Listing
Private
Website:
Address:
219 Terry Ave N
Suite 300
Seattle, WA 98109-5208
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.